The Business Research Company’s Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth And Change To 2030
LONDON, GREATER LONDON, UK, April 19, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
Increasing number of cancer patients is a major driver for the stem cell and global cord blood market. Cancer diseases such as leukemia and multiple myeloma can be treated by stem cell transplant. In stem cell transplant, treatment can be either done by autologous transplant, in which the stem cells come from the same person who gets the transplant, or by allogeneic transplant, in which the stem cells come from a matched related or unrelated donor. By using stem cells in the treatment of cancer, the blood forming stem cells which are damaged during chemotherapy can be restored. According to the American Cancer Society, in 2019, around 606,880 deaths were caused in USA due to prevalence of the cancer which can be treated by transplanting the stem cells.
The stem cell/cord blood banking market covered in this report is segmented by cell type into adult stem cells, umbilical cord blood stem cells, embryonic stem cells. The stem cell/cord blood banking global market is also segmented by service into collection, processing, analysis, storage, by bank type into public, private, by application into leukemia, anemia, thalassemia, autism, cerebral palsy, diabetes, others.
Read More On The Global Stem Cell/Cord Blood Banking Market Report:
The global stem cell/cord blood banking market is expected to grow from $8.16 billion in 2020 to $8.61 billion in 2021 at a compound annual growth rate (CAGR) of 5.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The stem cell blood banking market is expected to reach $12.51 billion in 2025 at a CAGR of 9.8%.
Major players in the stem cell and cord blood banking industry are AMAG Pharmaceuticals, Cordlife, Cryo-Cell International, Esperite, and Americord Registry LLC.
Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides stem cell/cord blood banking market overview, forecast stem cell/cord blood banking market size and growth for the whole market, stem cell/cord blood banking market segments, and geographies, stem cell/cord blood banking market trends, stem cell/cord blood banking market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Stem Cell/Cord Blood Banking Market Report:
Here Is A List Of Similar Reports By The Business Research Company:
Biobank Market – By Specimens Type (Blood Products, Cell Lines, Nucleic Acids And Human Tissues), And By Region, Opportunities And Strategies – Global Forecast To 2023
Patient Blood Management Global Market Report 2021: COVID-19 Growth And Change To 2030
Stem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030
Induced Pluripotent Stem Cell (iPSC) Global Market Report 2021: COVID-19 Growth And Change To 2030
Blood Transfusion Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030
Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293